An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · The Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals i…
VERDICT
The label
Markup
read at $390.35
Travelers Companies (The) holds its Markup at $390.35.
PHPhase · the trend structure carries the Markup label
INInsiders · no filings inside 60 days, left as found
POPositioning · no disclosures inside 60 days, left as found
OPOptions · no verdict drawn today, left as found
SCScreen · does not pass the values gate
edge confirmed
edge broken
edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
INVESTOR
The investor read · the season, not the day
As held on the ledger · 2026-07-27
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 2 days
Price
$390.35
Valuation
10.49 trailing · 12.97 forward price to earnings
Values screen
FAIL· score 10.0
Beta
0.47
OPPORTUNITY
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades above our $310.98 fair value estimate, moderate competitive moat, 0.30% revenue growth.
Read at
$390.35
10.49 P/E · 12.97 fwd
Our fair value
$310.98
20% premium
Analyst target (avg)
$351.00
-10% to current
Target low $262.00Analyst target rangeTarget high $430.00
▲ current $390.35 · | average target
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Current
$390.35
you are here
Conservative
$240.86
-38%
Analyst avg
$351.00
-10%
Our fair value
$310.98
-20%
Analyst high
$430.00
+10%
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the Street see limited upside at this price.
Revenue growth
0.30%
Profit margin
16.95%
Debt to equity
27.38
Analyst consensus
Hold · 24 covering
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
SCREEN
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
The common standard· AAOIFI Used by most halal investing apps✗ DOES NOT PASS
Our stricter standard· asset-based The one Titan applies✗ DOES NOT PASS
Why it fails. The problem is its business activity screen. Because both standards agree on this, it is a clear exclusion, not a borderline case.
Business activityBusiness activity: Financials sectorFail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
PLAIN
The business, in plain words · what the numbers mean
Insurer priced for growth it cannot deliver
Picture a homeowner paying premiums every month for the promise of cover when disaster strikes. Travelers has built a solid book of that business across the United States, yet revenue has flatlined and the shares now trade at 369 dollars against a fair value nearer 301 dollars.
We pass for two clear reasons. The forward multiple of 12.7 times offers little margin when growth sits at zero, while the ethical screen flags the business on activity grounds. A 27 percent return on equity and 17 percent profit margin look respectable, but they do not offset the valuation gap or the ethical breach.
The stock may drift with the broader market and analyst targets hover around 340 dollars, yet paying a premium for no growth while failing a basic values check is not a combination we accept. Analysis, not advice.
Screened names in the same industry · explore each on its own page.
TRADE
Where & how to trade · wherever in the world you are
TRV trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
TRADER
The trader read · the latest dated commentary
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (23 analysts) rates it hold, with a mean price target of $313. Entered 2026-07-18 · Accumulation
JOURNAL
The dated journal · newest first, never edited
2026-07-18Accumulation$303.25+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (23 analysts) rates it hold, with a mean price target of $313.
2026-07-03Accumulation$303.25+0.0%Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Accumulation$303.25Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
